2017 International Congress Archives - Page 155 of 155

Gait analysis as a complementary tool in the levodopa dose decision in Vascular Parkinson’s Disease

M. Gago, F. Ferreira, N. Mollaei, M. Rodrigues, N. Sousa, E. Bicho, P. Rodrigues (Braga, Portugal)
Gait Analysis in Orthostatic Tremor treated with Thalamic Deep Brain Stimulation

T.K. Tareen, A. Duker, G. Mandybur, J. Tuazon, M. Rosso, A. Espay, A. Fasano, A. Merola (Cincinnati, OH, USA)
Gait Analysis in Patients with Huntington’s Disease

Y.-M. Park, S. Pyo, H.-M. Lee, M.-J. Kim, S.-B. Koh (Seoul, Republic of Korea)
Gait and Balance Impairment After Methanol Intoxication

K. Peterová, H. Brožová, J. Klempíř, I. Lišková, S. Zakharov, O. Bezdíček, M. Vaněčková, Z. Seidl, E. Růžička (Prague, Czech Republic)
Gait and Cognition in Progressive Supranuclear Palsy: A Significant Association

K. Chatterjee, B. Mondal, S. Choudhury, H. Kumar (Kolkata, India)
Gait asymmetry and asymmetry index in a sample of patients with PD and control group in Cali – Colombia.

B. Munoz, A. Enriquez-Marulanda, J. Orozco (Cali, Colombia)
Gait Asymmetry and Parkinson’s Disease

C. Ashton, L. Solis-Cohen, L. Wagenaar, R. Laracuente, E. Sorberg, V. Vanderhorst, L. Shih (Boston, MA, USA)
Gait asymmetry in people with Parkinson’s disease is linked to reduced integrity of callosal sensorimotor regions

F. Horak, C. Curtze, B. Fling (Portland, OR, USA)
Gait characteristics in Atypical Parkinsonism

S. Radovanovic, M. Jecmenica-Lukic, I. Petrovic, N. Dragasevic-Miskovic, M. Svetel, V. Kostic (Belgrade, Serbia)
Gait characteristics of freezing in patients with Parkinson’s disease

S.-M. Cheon, S.-Y. Lee, J.W. Kim (Busna, Republic of Korea)
Gait disturbance and olfactory dysfunction is associated with central cholinergic dysfunction in early Parkinson’s disease

E. Oh, Y. Lim, S. Park (Daejeon, Republic of Korea)
Gait impairment and cognitive changes in a case of thalamic dementia and motor neuron disease.

S. O'Shea, O. Levy, J.P. Vonsattel, E. Cortes, K. Marder, H. Mitsumoto, R. Alcalay (New York, NY, USA)
Gait, Freezing of Gait and Falls detection using wearable sensors; a systematic review

A.L. Silvade Lima, L.JW. Evers, T. Hahn, L. Bataille, J.L. Hamilton, M.A. Little, B.R. Bloem, M.J. Faber (Nijmegen, Netherlands)
GammaKnife subthalamotomy for Parkinson’s disease

t. witjas, r. carron, a. eusebio, j.p. azulay, j. regis (marseille, France)
Gastroesophageal dysmotility in advanced Parkinson’s Disease

F. Mancini, M. Lacerenza, L. Manfredi, A. Bestetti (Milan, Italy)
Gastrointestinal transit time in Parkinson’s disease -a novel 3D method

K. Knudsen, T. Fedorova, K. Østergaard, K. Krogh, P. Borghammer (Aarhus, Denmark)
GBA mRNA is diminished in brain and blood of Lewy body diseases

K. Beyer, J. Campdelacreu, L. Ispierto, D. Vilas, R. Reñé, R. Alvarez (Badalona, Spain)
Gender differences in motor and non-motor features across the Parkinson’s disease spectrum

T. Dunne, G. Stebbins, C. Goetz, S. Luo, J. Goldman (Chicago, IL, USA)
Gene associated differences in pre-diagnostic symptoms of Parkinson’s Disease: a retrospective study

S. Liu, Z. Zheng, Z. Gu, C. Wang, J. An, H. Ding, M. Zhou, H. Zhang, X. Dan, Y. Li, M. Cao, S. Cen, T. Mi, P. Chan (Beijing, China)
General Anesthesia and Parkinson’s Disease

C.-W. CHEN, K.-B. CHEN, Y.-C. KUO (TAICHUNG, Taiwan)
Generalized choreodystonia in a patient with HIV and hepatitis C with the history of opioid drug abuse after treating with interferon- 2alpha (Peginton)

D. Khasanova, Z. Zalyalova (Kazan, Russian Federation)
Genetic analysis of RAB39B mutations in early-onset and familial Parkinson’s Disease in a Taiwanese population.

C.-H. Lin, H.-H. Lin, R.-M. Wu, H.-I. Lin (Taipei, Taiwan)
Genetic and Clinical Analysis of Cerebral Calcifications

V. Chelban, R. Kaiyrzhanov, H. Houlden (London, United Kingdom)
Genetic and pharmacological rescue of DJ-1 loss-of-function caused by a c.192G>C mutation in PARK7

I. Boussaad, C. Obermaier, Z. Hanss, N. Weisschuh, B. Schmid, S. Hoffmann, L. Burbulla, C. Klein, S. Duga, D. Krainc, T.G. Gasser, B. Wissinger, R. Krüger (Esch-sur-Alzette, Luxembourg)
Genetic knock-down of HDAC4 attenuates rotenone-induced abnormal expression of α-synuclein by affecting autophagic flux in SH-SY5Y Cells

L. Wang, J. Huang, L. Liu, C. Han, K. Ma, X. Guo, S. Guo, Y. Shen, Y. Xia, F. Wan, N. Xiong, T. Wang (Wuhan, China)
Genetic susceptibility associated to impulse control disorders and compulsive behaviors in Parkinson’s disease from a Spanish population.

S. JESUS, C. TEJERA-PARRADO, C. CORTES, M. BONILLA-TORIBIO, I. BERNAL-BERNAL, M. LABRADOR, L. VARGAS-GONZÁLEZ, M. BERNAL, A. ADARMES, F. CARRILLO, M. CARBALLO, P. GÓMEZ-GARRE, P. MIR (SEVILLA, Spain)
Genetic variants influencing dyskinesia; potential consequences for treatment in Parkinson’s disease

C. Kusters, K. Paul, I. Guella, J. Bronstein, J. Sinsheimer, M. Farrer, B. Ritz (Los Angeles, CA, USA)
Genetic variations in Amyloid-beta1-42 clearance proteins determine onset of dementia in Parkinson’s disease and dementia with Lewy bodies

K. Brockmann, S. Lerche, A. Apel, A.-K. Hauser, I. Liepelt Scarfone, D. Berg, T. Gasser, C. Schulte, W. Maetzler (Tübingen, Germany)
Genetic, epigenetic and expression profiles in alpha-synucleinopathies

E. Scott, I. Guella, A. Rajput, A. Rajput, L. Parkkinen, M. Kobor, M. Farrer (Vancouver, BC, Canada)
Genetics of impulse control disorders in Parkinson’s disease: a case control study

J.-C. Corvol, F. Cormier-Dequaire, S. Bekadar, S. Prud'hon, M. Anheim, J.-P. Azulay, F. Durif, J.-L. Houeto, A. Destée, K. Tahiri, G. Mangone, L. Lacomblez, P. Krack, P. Krystkowiak, D. Maltête, O. Rascol, C. Tranchant, M. Vidailhet, A. Brice, S. Tezenas duMontcel (Paris, France)
Genome-wide DNA methylation analysis reveals epigenetic perturbations in Parkinson disease.

J. Young, S. Sivasankaran, L. Wang, A. Ali, A. Mehta, D. Davis, K. Belle, D. Dykxhoorn, C. Petito, G. Beecham, E. Martin, D. Mash, W. Scott, J. Vance (Miami, FL, USA)
Genotype-Phenotype correlations and expansion of the molecular spectrum of AP4M1-related Hereditary Spastic Paraplegia

S. Efthymiou, C. Bettencourt, V. Salpietro Damiano, H. Houlden (London, United Kingdom)
Genotype-phenotype correlations in Parkinson disease patients who carry mutations in the GBA gene.

A. Thaler, T. Gurevich, A. Ezra, M. Kestenbaum, N. Giladi, A. Mirelman (Tel Aviv, Israel)
Ghrelin and the IGF-1 axis in cognitive impairment in PD

F. Johnston, M. Siervo, A. Hornsby, J. Davies, D. Burn (Newcastle upon Tyne, United Kingdom)
Global inhibitory control in PD is impaired ON dopaminergic medication but not ON STN-DBS

D. Kübler, H. Schroll, A. Kühn (Berlin, Germany)
Global Regulatory Agencies Support the Use of Dopamine Transporter Neuroimaging for Subject Selection in Clinical Trials Targeting Early Stage Parkinson’s Disease – on behalf of Critical Path for Parkinson’s (CPP) Consortium

D. Stephenson, J. Cedarbaum, J. Eberling, M. Facheris, D. Grosset, M. Gordon, D. Hill, S. Imam, V. Kern, G. Klein, D. Matthews, P. Muglia, A. Roach, K. Romero, D. Russell, J. Seibyl, L. Slieker, E. Somer, C. Sur, Z. Xie, K. Marek (Tucson, AZ, USA)
Globus Pallidus and Pedunculopontine Nucleus Oscillations during Executed and Imagined Gait in Patient with Parkinson’s Disease and Freezing of Gait Symptoms.

E. Opri, R. Molina, J. Shute, K. Foote, M. Okun, A. Gunduz (Gainesville, FL, USA)
Glucocerebrosidase mutations in idiopathic REM sleep disorder

K. Beyer, M. Serradell, J. Santamaria, C. Gaig, R. Alvarez, A. Iranzo (Badalona, Spain)
Glucocerebrosidase mutations in neurodegenerative disorders other than Parkinson’s disease

G. Buongarzone, C. Fenoglio, J. Nicoli, E. Monfrini, I. Trezzi, A. Arighi, R. Del Bo, N. Bresolin, E. Scarpini, G. Comi, S. Corti, A. Di Fonzo (Milan, Italy)
Glut-1 deficiency: a case report

P. Marques, H. Teive, F. Germiniani, V.C. Terra, C.E. Silvado, M. Canever, G. Tansini, L. Oliveira (Curitiba, Brazil)
Goal-Directed Movement in Idiopathic Parkinson’s Disease and the effect of Parkin Mutations

C. Fearon, T. Munteanu, D. Birsanu, L. Newman, B. Quinlivan, i. killane, B. Magennis, J. Butler, R. Reilly, T. Lynch (Dublin 7, Ireland)
Goalkeeper game: a novel test to identify early implicit learning alterations in people with Parkinson’s disease

M.E. Pimentel Piemonte, A. Galves, A. Frazao Helene, M. D'Alencar (Sao Paulo, Brazil)
Gpi DBS for Dystonia in Pediatric Patients

S. Aydın, H. Canaz (Istanbul, Turkey)
Gray Matter Density in Essential Tremor: A Lobule by Lobule Analysis of the Cerebellum

E. Louis, J. Dyke, E. Cameron, N. Hernandez, U. Dydak (New Haven, CT, USA)
Grey matter abnormalities associated with early cognitive decline in Parkinson’s disease

A. Moonen, R. Lopes, A. Leentjens, A. Duits, K. Dujardin (Maastricht, Netherlands)
Gut Microbiota in Multiple System Atrophy

A.H. Tan, C.W. Chong, S.-L. Song, C.S.-J. Teh, I.K.-S. Yap, M.F. Loke, Y.Q. Tan, H.S. Yong, S. Mahadeva, A.E. Lang, S.-Y. Lim (Kuala Lumpur, Malaysia)